Novo Nordisk, the Danish maker of the wildly popular Ozempic and Wegovy drugs used for weight loss, was downgraded due to competition from compounding as well …
InsuranceMarketWork & Careers
Category:
Work & Careers
-
-
This article was automatically published by finance.codetrip.uk.
-
This article was automatically published by finance.codetrip.uk.
-
InsuranceMarketWork & CareersUBS downgrades Novo Nordisk rating, citing “challenging” business conditions
This article was automatically published by finance.codetrip.uk.
-
-
-
-
-
-
